Specifically, as compared with controls, they had less prevalent diagnosis of heart failure, reported a less prevalent use of benzodiazepines, and a more prevalent use of antiplatelets; also, they showed lower serum albumin levels; eventually, participants with a good quality of sleep had a more prevalent diagnosis of MetS. This evidence concerns the gene ALB and metabolic syndrome.